{
    "title": "British drug giant GlaxoSmithKline could swoop on consumer healthcare arms of US rival Pfizer and Germany\u2019s Merck",
    "url": "https://www.dailymail.co.uk/money/markets/article-5017341/GlaxoSmithKline-plots-foreign-takeover-bonanza.html",
    "date": "2017-10-25",
    "keywords": [
        "glaxo",
        "consumer",
        "pfizer",
        "merck",
        "healthcare",
        "year",
        "drug",
        "walmsley",
        "division",
        "arm",
        "oil",
        "strategy",
        "cent",
        "share",
        "health",
        "glaxosmithkline",
        "executive",
        "emma",
        "way",
        "panadol",
        "painkiller",
        "advil",
        "spending",
        "spree",
        "divisionany",
        "bid",
        "competition",
        "durex",
        "cillit",
        "bang",
        "owner",
        "reckitt",
        "benckiser",
        "acquisition",
        "trailwalmsley",
        "complementarity",
        "power",
        "brand",
        "footprint",
        "dividend",
        "company",
        "month",
        "sale",
        "fate",
        "era",
        "market",
        "report",
        "blow",
        "article",
        "income",
        "sensodynewalmsley",
        "research",
        "minority",
        "stake",
        "venture",
        "novartis",
        "partner",
        "cost",
        "yesterday",
        "rise",
        "thirdquarter",
        "salesit",
        "failure",
        "lung",
        "inhaler",
        "advair",
        "boost",
        "hiv",
        "vaccine",
        "shingrix"
    ],
    "category": [
        "money",
        "markets"
    ]
}